|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02984 NEW RAY MED-8K
Nominal 
0.365 0.000 (0.000%) | 2026/06 - Interim HKD(K$) | 2025/12 HKD(K$) | 2024/12 HKD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | (54,142) | (4,766) |
| Net Cash from / (used in) Investing Activities | -- | 8,005 | (30,902) |
| Net Cash from / (used in) Financing Activities | -- | 6,113 | (1,581) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (40,024) | (37,249) |
| Cash & Cash Equivalents at beginning of period | -- | 64,255 | 103,954 |
| Effect of Foreign Exchange Rate Changes | -- | 5,186 | (2,450) |
| Others | -- | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 29,417 | 64,255 |
| Remarks: | Real time quote last updated: 13/11/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD -3,565 |
| %Change | -52.173% |
| EPS / (LPS) | HKD -0.018 |
| NBV Per Share ($) | HKD 2.173 |